Editor's Note A quality improvement study led by clinicians at the Mayo Clinic in Jacksonville, FL, improved clinical alarm management skills and reduced alarm fatigue and desensitization among nurses in a surgical intensive care unit. The study included 115 direct-care nurses working full-time, modified full-time, or part-time schedules in a…
Editor's Note Those who experience anxiety and depression months after a mild case of COVID-19 may have brain changes that affect its function and structure, finds a study that will be presented at the American Academy of Neurology’s Annual Meeting in April. The study, by researchers at the University of…
Editor's Note This study led by researchers at Cedars Sinai Medical Center, Los Angeles, finds that underrepresentation of minorities persists across all surgical specialties, while representation of females improves. The cross-sectional study examined race, ethnicity and attrition data of 112,205 surgical residents across 18 years (2001-2018) in 10 surgical specialties.…
Editor's Note The Joint Commission on October 5 announced that refreshed Accelerate PI Dashboard Reports are available for primary and comprehensive stroke centers to provide performance measurement data on the quality measures selected for advanced certification. The reports contain data through the first quarter of 2022 and are intended to…
Editor's Note The Food and Drug Administration (FDA) on August 31 identified the recall by Integra of its CereLink ICP Monitor as Class I, the most serious. The recall was initiated because the device may display incorrect values for a patient’s intracranial pressure (ICP) and display out-of-range pressure readings. If…
Editor's Note The Food and Drug Administration (FDA) on October 6 identified the recall by Imperative Care Inc of its ZOOM 71 Reperfusion Catheter as Class I, the most serious. The ZOOM 71 Reperfusion Catheter is used to remove blood clots from a patient’s brain within 8 hours of an…
Editor's Note The Food and Drug Administration (FDA), on September 20, identified Medtronic’s recall of its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology as Class I, the most serious. The devices, which are used to treat brain aneurysms, were recalled because there is a risk…
Editor's Note The Joint Commission on March 3 announced that it is extending the reduced volume eligibility requirements for its advanced Thrombectomy-Capable Stroke Center (TSC) and Comprehensive Stroke Center (CSC) certification programs through May 31 because the number of patients seeking care for strokes continues to vary because of COVID-19.…
Editor's Note The American College of Surgeons (ACS) on August 4 announced that it is strongly opposed to the Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule proposed rule for CY 2021. In the fee schedule, which is set to take place January 1, 2021, Medicare payments will…
Editor's Note As hospitals face a surge of COVID-19 patients, the ability for them to care for trauma cases and medical and surgical emergencies is severely compromised. Because of this, the American College of Surgeons (ACS) on April 7 issued a statement calling for strategies to preserve capacity and capability…